Autoimmune manifestations associated with myelodysplastic syndrome predict a poor prognosis

We evaluated the clinical characteristics of autoimmune manifestations (AIMs) associated with myelodysplastic syndrome (MDS) to elucidate whether AIMs impacted MDS outcomes in Japan. This retrospective study including 61 patients who received a new diagnosis of MDS between January 2008 and December...

Descripción completa

Detalles Bibliográficos
Autores principales: Arinobu, Yojiro, Kashiwado, Yusuke, Miyawaki, Kohta, Ayano, Masahiro, Kimoto, Yasutaka, Mitoma, Hiroki, Akahoshi, Mitsuteru, Miyamoto, Toshihiro, Horiuchi, Takahiko, Akashi, Koichi, Niiro, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021323/
https://www.ncbi.nlm.nih.gov/pubmed/33787649
http://dx.doi.org/10.1097/MD.0000000000025406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021323/
https://www.ncbi.nlm.nih.gov/pubmed/33787649
http://dx.doi.org/10.1097/MD.0000000000025406

Ejemplares similares